DalsnaFinance › IPOs › Foghorn Therapeutics Inc › IPO

Foghorn Therapeutics Inc. IPO

Completed

Foghorn Therapeutics Inc. completed its initial public offering on NASDAQ on October 23, 2020, pricing at $16.00 a share.

Ticker	FHTX
Exchange	NASDAQ
Status	Completed
Listing date	October 23, 2020
Offering price	$16.00
Shares offered	7,500,000
Total raised	$120M

The offering

Foghorn Therapeutics Inc. sold 7,500,000 shares at $16.00 each on NASDAQ. Multiplied out, that is $120 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $120 million total recorded for the deal.

Company coverage

Foghorn Therapeutics Inc. — quote, profile and latest news →

Other recent IPOs

Iambic Therapeutics, Inc. · October 13, 2026
Retension Pharmaceuticals, Inc. · October 8, 2026
Frazier Life Sciences Acquisition Corp. II · October 8, 2026
TRex Bio, Inc. · October 6, 2026
Pine Tree Acquisition Corp. · October 5, 2026
Accelevation Holdings Corp. · September 30, 2026
Southport Acquisition Corp. II · September 30, 2026
ROZE AI INC. · September 28, 2026

Source: SEC EDGAR filings for Foghorn Therapeutics Inc.. This page is general information, not investment advice.